Dr. Hossein Ameri, MD

Dr. Ameri practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Ameri's NPI, 1245467687, was assigned on June 12, 2009. Dr. Ameri graduated from Tehran University of Medical Sciences School of Medicine in 1993. Dr. Ameri holds California license A34789.

Dr. Ameri's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Ameri's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Ameri is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Ameri to 1 more group practice or clinic and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ameri practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Ameri's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Ameri is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Ameri's licenses on file in 2 states: California and Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and hypertensive retinopathy among the conditions Dr. Ameri treats.

CMS data shows 2,216 Medicare services from Dr. Ameri across 10 procedure codes in 2024, for 368 Medicare patients. Medicare paid $226,575 for them.

CMS counts 368 Medicare patients who saw Dr. Ameri in 2026. The largest group is 65 to 74, with 142 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ameri's median patient age at 69, with 48% women.

In 2026, Dr. Ameri wrote 101 Medicare Part D claims for 39 patients. 30% of them were for generic drugs. CMS names the drug for 61 of them, across 2 drugs with 11 or more claims each, at $6,289 in total drug cost. In 2023, CMS named 71 claims across 2 drugs.

Dr. Ameri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ameri as offering telehealth.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Ameri, published from 2012 to 2025. 2018 was the busiest year, with 3. Dr. Ameri has published most often in Ophthalmol Sci. Dr. Ameri's most frequent co-authors are Mark S. Humayun, MD, John C. Araujo, MD, PhD and Kavita V. Bhavsar, MD.

CMS Open Payments shows 45 general payments to Dr. Ameri from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 90% of the total. Spark Therapeutics, Inc. paid the most, $35,201.

Dr. Ameri graduated from Tehran University of Medical Sciences School of Medicine in 1993.

Dr. Ameri is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.